Treatment of Glioma in the 21st Century: An Exciting Decade of Postsurgical Treatment Advances in the Molecular Era
Authors:
- 1 June 2017
- journal article
- review article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 92 (6) , 995-1004
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- A phase III randomized controlled trial of short-course radiotherapy with or without concomitant and adjuvant temozolomide in elderly patients with glioblastoma (CCTG CE.6, EORTC 26062-22061, TROG 08.02, NCT00482677).Journal of Clinical Oncology, 2016
- Glioblastoma and Other Malignant GliomasJAMA, 2013
- Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trialThe Lancet Oncology, 2012
- Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trialThe Lancet Oncology, 2012
- An extent of resection threshold for newly diagnosed glioblastomasJournal of Neurosurgery, 2011
- Bevacizumab Plus Irinotecan in Recurrent Glioblastoma MultiformeJournal of Clinical Oncology, 2007
- Radiotherapy for Glioblastoma in the ElderlyNew England Journal of Medicine, 2007
- MGMTGene Silencing and Benefit from Temozolomide in GlioblastomaNew England Journal of Medicine, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Abbreviated Course of Radiation Therapy in Older Patients With Glioblastoma Multiforme: A Prospective Randomized Clinical TrialJournal of Clinical Oncology, 2004